Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PET Imaging and Protein Expression of Prostate-Specific Membrane Antigen in Glioblastoma: A Multicenter Inventory Study.
van Lith SAM, Pruis IJ, Tolboom N, Snijders TJ, Henssen D, Ter Laan M, Te Dorsthorst M, Leenders WPJ, Gotthardt M, Nagarajah J, Robe PA, De Witt Hamer P, Hendrikse H, Oprea-Lager DE, Yaqub M, Boellaard R, Wesseling P, Balvers RK, Verburg FA, Harteveld AA, Smits M, van den Bent M, van Zanten SEMV, van de Giessen E. van Lith SAM, et al. Among authors: hendrikse h. J Nucl Med. 2023 Oct;64(10):1526-1531. doi: 10.2967/jnumed.123.265738. Epub 2023 Aug 31. J Nucl Med. 2023. PMID: 37652540
Pharmacological Optimization of PSMA-Based Radioligand Therapy.
van der Gaag S, Bartelink IH, Vis AN, Burchell GL, Oprea-Lager DE, Hendrikse H. van der Gaag S, et al. Among authors: hendrikse h. Biomedicines. 2022 Nov 23;10(12):3020. doi: 10.3390/biomedicines10123020. Biomedicines. 2022. PMID: 36551776 Free PMC article. Review.
Relationship between Biodistribution and Tracer Kinetics of 11C-Erlotinib, 18F-Afatinib and 11C-Osimertinib and Image Quality Evaluation Using Pharmacokinetic/Pharmacodynamic Analysis in Advanced Stage Non-Small Cell Lung Cancer Patients.
van de Stadt EA, Yaqub M, Schuit RC, Bartelink IH, Leeuwerik AF, Schwarte LA, de Langen AJ, Hendrikse H, Bahce I. van de Stadt EA, et al. Among authors: hendrikse h. Diagnostics (Basel). 2022 Apr 1;12(4):883. doi: 10.3390/diagnostics12040883. Diagnostics (Basel). 2022. PMID: 35453931 Free PMC article.
Prospective analysis of clinically significant prostate cancer detection with [18F]DCFPyL PET/MRI compared to multiparametric MRI: a comparison with the histopathology in the radical prostatectomy specimen, the ProStaPET study.
Bodar YJL, Zwezerijnen BGJC, van der Voorn PJ, Jansen BHE, Smit RS, Kol SQ, Meijer D, de Bie K, Yaqub M, Windhorst BAD, Hendrikse HNH, Vis AN, Oprea-Lager DE. Bodar YJL, et al. Among authors: hendrikse hnh. Eur J Nucl Med Mol Imaging. 2022 Apr;49(5):1731-1742. doi: 10.1007/s00259-021-05604-9. Epub 2021 Nov 2. Eur J Nucl Med Mol Imaging. 2022. PMID: 34725727 Free PMC article.
Shaping Tin Nanocomposites through Transient Local Conversion Reactions.
Hendrikse HC, Hémon-Charles S, Helmbrecht L, van Dam EP, Garnett EC, Noorduin WL. Hendrikse HC, et al. Cryst Growth Des. 2021 Aug 4;21(8):4500-4505. doi: 10.1021/acs.cgd.1c00393. Epub 2021 Jul 15. Cryst Growth Des. 2021. PMID: 34381311 Free PMC article.
Predicting early outcomes in patients with intermediate- and high-risk prostate cancer using prostate-specific membrane antigen positron emission tomography and magnetic resonance imaging.
Meijer D, van Leeuwen PJ, Donswijk ML, Boellaard TN, Schoots IG, van der Poel HG, Hendrikse HN, Oprea-Lager DE, Vis AN. Meijer D, et al. Among authors: hendrikse hn. BJU Int. 2022 Jan;129(1):54-62. doi: 10.1111/bju.15492. Epub 2021 Jun 16. BJU Int. 2022. PMID: 34028165 Free PMC article.
22 results